D-0255-2026 Class II Ongoing

Recalled by SpecGx, LLC — Webster Groves, MO

FDA drug recall D-0255-2026 was initiated by SpecGx, LLC on Dec 16, 2025 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. The recall status is ongoing. Affected quantity: 74,544 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 14, 2026
Initiation Date
Dec 16, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
74,544 bottles

Product description

Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493

Reason for recall

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Distribution pattern

Nationwide

Code information

Lot: 0522J23493, expires: 03/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0255-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0255-2026. Report a data issue: hello@regdatalab.com.